SlideShare a Scribd company logo
1 of 45
Jian-Hwa Han
USP Expert Panel Meeting
May 29-30, 2013
Using Enzymes for
Dissolution - The
Understandings from
Gelatin to Enzymes
SUB-TITLE, DATE
• Dissolution Equipment and Apparatus
• Gelatin Dissolution in Various Media
• Reference Compound – Acetaminophen
o Tablet vs. OE Capsule (Over-encapsulated Tablet sample)
• Tier-2 Testing Performance Evaluation
o Enzymes Information
o Control of Experiments
o Setting the Reference Point - <711> Pepsin
o Equivalent Performance of other Enzymes
o Reproducibility of Bromelain and Papain
o Disintegration Evaluation
• Summary & Next Step
Presentation Outline
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
2
Dissolution by FO-UV System
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
3
• System 1: Distek Opt-Diss FO-UV Dissolution System
• System 2: Sotax with Rainbow FO-UV System
• Advantage: Direct detection with details profiles
(and w/o Sampling errors)
• Apparatus 2 @ 50 rpm
• Samples
• Hard Gelatin Shell
• Tylenol Tablet
• OE Tylenol Sample
• Cross-linked OE Tylenol Sample
Gelatin Dissolution
– The Basics
Gelatin Dissolution – Typical Media
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
5
• Data clearly
show much
faster
dissolution rate
in 0.1N HCl
• The dissolution
rates in pH 4.5,
pH 6.8, and
water are
similar
Dissolution of Hard Gelatin Shell - App 2 @ 50 rpm
in Typical Dissolution Media
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0.0 10.0 20.0 30.0 40.0 50.0 60.0
Time, Minutes
%LC
0.1N HCl Acetate, pH 4.5 Phosphate, pH 6.8 Water
Gelatin Dissolution –
Surfactant Impact in Water
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
6
• Surfactants do
slow down the
dissolution of
gelatin
• The impact
from POE and
CTAB are not
significant
• SDS posts more
impact, but it
still within the
variability
Dissolution of Hard Gelatin Shell - App 2 @ 50 rpm
Surfactant Impact in Water
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0.0 10.0 20.0 30.0 40.0 50.0 60.0
Time, Minutes
%LC
Water 0.5% SDS in Water 0.5% POE in Water 0.2% CTAB in Water
Gelatin Dissolution –
Surfactant Impact in pH 6.8 Phosphate Media
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
7
• No significant
impact
observed in
pH 6.8
Phosphate
media with
either SDS or
POE10LE
Dissolution of Hard Gelatin Shell - App 2 @ 50 rpm
Surfactant Impact in pH 6.8 Phophaste Buffer
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0.0 10.0 20.0 30.0 40.0 50.0 60.0
Time, Minutes
%LC
0.5% SDS in pH 6.8 pH 6.8 Buffer 0.5% POE in pH 6.8
Gelatin Dissolution –
Surfactant Impact in 0.1N HCl Media
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
8
• No significant
impact
observed for
POE in
0.1N HCl media
• Significant
impact
observed for
SDS in 0.1N HCl
media!!!
Dissolution of Hard Gelatin Shell - App 2 @ 50 rpm
Surfactant Impact in 0.1N HCl
0.0
20.0
40.0
60.0
80.0
100.0
120.0
0.0 10.0 20.0 30.0 40.0 50.0 60.0
Time, Minutes
%LC
0.5% SDS in HCl 0.1N HCl 0.5% POE in HCl
Comparison of Gelatin Dissolution Time in
Various Media
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
9
Note – In general, the capsule opens within 2 minutes in 0.1N HCl.
Gelatin Dissolution Comparison
0
5
10
15
20
25
30
0.1
N
HC
l,900
m
L
0.5%
SDS/0.1N
H
C
l
0.5%
PO
E/0.1N
H
Cl
Phosphate,pH
6.8
0.5%
SDS/pH
6.8
0.5%
PO
E/pH
6.8
W
ater,900
m
L
0.5%
SDS/W
ater
0.5%
PO
E/W
ater
0.2%
CTAB/W
ater
Time,Minutes
>~25% Dissolved
>~50% Dissolved
Reference Drug
Acetaminophen
(Tylenol IR Tablet):
Q: NLT 80% in 30 min.
Reference Compound – Acetaminophen
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
11
• Tylenol 250 mg
Tablet was used as
the test drug
• Size 0 HGC Used for
the OE sample
without filler
Tablet vs. OE Capsule Dissolution – Typical Media
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
12
Gelatin Dissolution Research - Acetaminophen, 0.1N HCl
0
20
40
60
80
100
120
0 5 10 15 20 25 30
Time, Min.
%LC
HGC Shell Tylenol OE Capsule Tylenol Tablet
Gelatin Dissolution Research - Acetaminophen, Water
0
20
40
60
80
100
120
0 5 10 15 20 25 30
Time, Min.
%LC
HGC Shell Tylenol OE Capsule Tylenol Tablet
Gelatin Dissolution Research - Acetaminophen, pH 6.8
0
20
40
60
80
100
120
0 5 10 15 20 25 30
Time, Min.
%LC
HGC Shell Tylenol OE Capsule Tylenol Tablet
Gelatin Dissolution Research - Acetaminophen, pH 4.5
0
20
40
60
80
100
120
0 5 10 15 20 25 30
Time, Min.
%LC
HGC Shell Tylenol OE Capsule Tylenol Tablet
Full release (>85%) within
3 minutes from Tablet
(for all conditions)
Once capsule opens, the
residual gelatin does not
impact dissolution for this
product.
Full release (>85%) within
10 minutes from OE
Capsule (for all conditions)
0.1N HCl pH 4.5
pH 6.8 Water
Acetaminophen OE Capsule Dissolution –
Surfactant Impact (in Water)
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
13
• Surfactant
somewhat
delays the drug
release
• SDS: high
capsule-to-
capsule
variability
• However, all
conditions
release >85% in
10 minutes
Gelatin Dissolution Research - Acetaminophen OE Capsule,
Surfactant Impact (in Water)
0
20
40
60
80
100
120
0 5 10 15 20 25 30
Time, Min.
%LC
Water Only 0.5% Tween-80 0.5% POE 0.5% CTAB 0.5% SDS
Acetaminophen OE Capsule Dissolution –
Surfactant Impact (in 0.1N HCl)
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
14
• Surfactants do
NOT slow down
the drug release
in 0.1N HCL
• CTAB and POE
show slightly
faster drug
release rate
(Very low gelatin
dissolution rate in
0.5% SDS/HCl does
not impact the
drug release from
OE Capsules – see
slide #16)
Gelatin Dissolution Research - Acetaminophen OE Capsule,
Surfactant Impact (in 0.1N HCl)
0
20
40
60
80
100
120
0 5 10 15 20 25 30
Time, Min.
%LC
0.1N HCl only 0.5% SDS 0.5% CTAB 0.5% POE Gelatin_SDS/HCl
Acetaminophen OE Capsule Dissolution –
Surfactant Impact (in pH 6.8 Phosphate)
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
15
• CTAB delays the
capsule opening
(> 5minutes)
• SDS shows very
high capsule-to-
capsule
variability, and
did not release
>85% at 10
minutes
Gelatin Dissolution Research - Acetaminophen OE Capsule,
Surfactant Impact (in pH 6.8 Phosphate)
0
20
40
60
80
100
120
0 5 10 15 20 25 30
Time, Min.
%LC
pH 6.8 Phosphate only 0.5% SDS 0.5% CTAB 0.5% POE
Acetaminophen OE Capsule Dissolution –
SDS (at 0.5%) Impact in Different Media
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
16
• More variable
in water and pH
6.8 Phosphate
• SDS/pH 6.8: did
not release
>85% at 10
minutes
• However, all
conditions can
release >85% of
drug in 15
minutes
Gelatin Dissolution Research - Acetaminophen OE Capsule,
SDS Impact in Various Media
0
20
40
60
80
100
120
0 5 10 15 20 25 30
Time, Min.
%LC
Water Only SDS in Water SDS in HCl SDS in pH 6.8
Comparison of Acetaminophen Dissolution Time:
Tablet vs. OE Capsule in Various Media
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
17
• The Tablet full releases the drug within 3 minutes (> 90% for all media tested)
• The OE Capsule releases >85% drug within 10 minutes for all conditions tested
Acetaminophen Dissolution Comparison - Tablet vs. OE Capsule (Tier-1)
0
1
2
3
4
5
6
7
8
9
10
0.1N
H
Cl, Tablet
0.1N
H
Cl, O
E
C
apsule
0.5%
SDS/0.1N
H
C
l_C
ap
pH
4.5, Tablet
pH
4.5, O
E
Capsule
pH
6.8, Tablet
pH
6.8, O
E
Capsule
0.5%
CTAB/pH
6.8_C
ap
W
ater, Tablet
0.5%
Tween-80, Tablet
W
ater, O
E
C
apsule
0.5%
Tween-80, O
E
C
ap
0.5%
SDS, O
E
C
apsule
0.5%
PO
E, O
E
C
apsule
0.5%
CTAB, O
E
C
apsule
Time,Minutes
>=5% Release >=85% Released
Tier-2 Testing
Performance
Evaluation
Enzymes Information (Currently in USP <711>)
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
19
Pepsin:
• Manufacture: American
Laboratories Inc.
• Product: Pepsin, 1:10,000
Powder
• Lot No: 00511010
• Pepsin Activity: 1:10,400
Pacreatin:
• Manufacture: American
Laboratories Inc.
• Product: Pancreatin 8X USP
Powder
• Lot No: 52320708
• Activity:
Protease: 8.1X USP (203 USP units/mg)
Amylase: 10.2X USP
(255 USP units/mg)
Lipase: 33.7 USP Units/mg
Enzymes Information (New)
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
20
Bromelain:
• Manufacture: American
Laboratories Inc.
• Product: Bromelain 2400 GDU
• Lot No: 55920701-A
• Proteolytic Activity:
2,482 GDU/g
Papain:
• Manufacture: American
Laboratories Inc.
• Product: Papain Full Strength
• Lot No: 70310665-B
• Proteolytic Activity:
66,900 USP units/mg
Control of Experiments
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
21
Need to get Reproducible results! (Consistency!)
• Same Equipment and Apparatus
• Same Analyst
• Consistent Execution of Dissolution Runs
• Direct Detection – Avoid sampling errors
• Precise operation for generating cross-linked capsule
samples: 2-hour Treatment with Formaldehyde
<711> Tier-1 vs. Tier-2:
Non-cross-linked Capsules
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
22
• No significant
difference after 10
minutes
Normal Capsule - 0.1N HCl
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
0.1N HCl/Pepsin 0.1N HCl
Normal Capsule - pH 6.8
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
pH 6.8 pH 6.8/Pancreatin
Q: NLT 80% in 30 min.
Tier-1, 0.1N HCl:
Non-cross-linked Capsule vs. Cross-linked Capsule
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
23
• Fails Stage-3!
• The ~same
level of cross-
linked capsule
samples (i.e. 2-
hour treated)
were used for
all Tier-2
experiments
Tier-1, 0.1N HCl: Normal Capsule vs. X-linked Capsule
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_Tier-1_HCl Xlinked_Tier-1_HCl
Q: NLT 80% in 30 min.
Tier-1, pH 6.8:
Non-cross-linked Capsule vs. Cross-linked Capsule
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
24
• Fails Stage-3!Tier-1, pH 6.8: Normal Capsule vs. X-linked Capsule
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_Tier-1_pH 6.8 Xlinked_Tier-1_pH 6.8
Q: NLT 80% in 30 min.
<711> Pepsin, 750,000 Units/L
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
25
• Current <711>
750,000 units/L
is equivalent to
16,000,000 FCC
units/L
• For X-linked
capsule (2-hour
treated with
formaldehyde),
Tier-2 result at
30 minutes is
92% (± 6.2%)
May Pass S-1
of Tier-2
<711> Pepsin @ 750,000 Units/L
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_Tier-1_HCl Xlinked_Tier-2_HCl
<711> Pancreatin, 1750 Units/L
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
26
• Current <711>
1750 units/L
• For X-linked
capsule (2-hour
treated with
formaldehyde),
Tier-2 result at
30 minutes is
83% (± 10.6%)
Will go to
Stage-2 of
Tier-2
<711> Pacreatin @ 1750 Units/L
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_Tier-1_pH 6.8 Xlinked_Tier-2_pH 6.8
Finding Equivalent Pancreatin Level to Match
Pepsin Performance
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
27
• Current <711>
1750 units/L
(1X)
• Levels tested:
[Units/L]
1750 (1X), 2000,
2500, 3500 (2X),
and 5250 (3X)
• For 2000 Units/L,
Tier-2 result at
30 minutes is
93% (± 4.0%)
 May Pass S-1
of Tier-2
pH 6.8 / Pancreatin
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_Tier-2 Normal_Tier-1 Xlinked_Tier-1
Xlinked_Tier-2_3X Xlinked_Tier-2_2X Xlinked_Tier-2_1X
Xlinked_Tier-2_2500U Xlinked_Tier-2_2000U
1750 Units/L
2000 Units/L
5250 Units/L (3X)
pH 6.8 / Pancreatin
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_Tier-1 Xlinked_Tier-1 Xlinked_Tier-2_1X
Xlinked_Tier-2_2000U Pepsin, <711>
Pancreatin vs. Pepsin Performance
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
28
Pepsin, <711>
Tier-1, pH 4.5:
Non-cross-linked Capsule vs. Cross-linked Capsule
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
29
• Fails Stage-3!
Tier-1, pH 4.5: Normal Capsule vs. X-linked Capsule
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_Tier-1_pH 4.5 Xlinked_Tier-1_pH 4.5
Q: NLT 80% in 30 min.
Screening Bromelain at pH 4.5 to Match Pepsin
Performance
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
30
• Starting point:
0.5 g/L (i.e.
~1250 GDU/L)
• Levels tested:
[GDU/L]
1250, 500, 100,
50, 40, 30, and
25 GDU/L
• For 30 GDU/L,
Tier-2 result at
30 minutes is
91% (± 7.0%)
 Will Pass S-2
of Tier-2
pH 4.5 / Bromelain
0
20
40
60
80
100
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_Tier-1 X_Tier-1 X_Tier-2 (1250U)
X_Tier-2 (500U) X_Tier-2 (100U) X_Tier-2 (50U)
X_Tier-2 (40U) X-Tier-2 (30U) X-Tier-2 (25U)
Very Effective!
25 GDU/L
Bromelain vs. Pepsin Performance
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
31
pH 4.5 / Bromelain
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_Tier-1 Xlinked_Tier-1 Xlinked-Tier-2 (30U)
Xlinked-Tier-2 (25U) Pepsin, <711>
Pepsin, <711>
Screening Papain at pH 4.5 to Match Pepsin
Performance
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
32
• Starting point:
9 mg/L (i.e.
~600,000 U/L)
• Levels tested:
[KU/L]
600, 550, 525,
and 500 KU/L
• Very small
amount of
Papain Used:
pH 4.5 / Papain
0
20
40
60
80
100
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_T1 X_T1 X_Tier-2 (600KU)
X_Tier-2 (550KU-1) X_Tier-2 (550KU-2) X_Tier-2 (525KU-1)
X_Tier-2 (525KU-2) X_Tier-2 (500KU)
Units/L mg / 6L
600,000 53.8
550,000 49.3
525,000 47.1
500,000 44.9
Screening Papain at pH 4.5 to Match Pepsin
Performance (cont.)
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
33
• The results seem
more variable
than Bromelain
• For 550 KU/L,
Tier-2 result at
30 minutes is
95% (± 3.0%)
 Too Good?
• For 525 KU/L,
Tier-2 result at
30 minutes is
85% (± 9.9%)
 Will go to
Stage-2 of Tier-2
pH 4.5 / Papain
0
20
40
60
80
100
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_T1 X_T1 X_Tier-2 (600KU)
X_Tier-2 (550KU, N=12) X_Tier-2 (525KU, N=12)
525 KU/L
Papain vs. Pepsin Performance
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
34
pH 4.5 / Papain
0
20
40
60
80
100
120
0 10 20 30 40 50 60
Time, Minutes
%LC
Normal_T1 Xlinked_T1
Xlinked_Tier-2 (550KU, N=12) Xlinked_Tier-2 (525KU, N=12)
Pepsin, <711>
Pepsin, <711>
Stability of Papain Medium at 550,000 Units/L
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
35
• X-linked Capsule
/ Tier-2 Testing:
Levels =
550 KU/L
• After 7 hours,
Tier-2 result at
30 minutes is
78% (± 15.3%)
 May Fail the
Tier-2
pH 4.5 / Papain, ~550 KU/L
0
20
40
60
80
100
0 10 20 30 40 50 60
Time, Minutes
%LC
Papain 550 kU-1 Papain 550 kU-2 Papain 550 kU_7 Hours
Stability of Papain Medium at 525,000 Units/L
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
36
• X-linked Capsule
/ Tier-2 Testing:
Levels =
525 KU/L
• Up to 4 hours,
the dissolution
rate did not slow
down
• Overall, it shows
high variability
from run-to-run
using Papain at
550 KU/L and
525 KU/L
pH 4.5 / Papain, ~525 KU/L
0
20
40
60
80
100
0 10 20 30 40 50 60
Time, Minutes
%LC
Papain 525 kU-1 Papain 525 kU-2 Papain 525 kU_4 Hours
Stability of Bromelain Medium at 30 GDU/L
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
37
• X-linked Capsule
/ Tier-2 Testing:
Levels =
30 GDU/L
• The dissolution
rate are very
consistent up to
4 hours
• After 7 hours,
Tier-2 result at
30 minutes is
70% (± 9.6%)
 May Fail the
Tier-2
pH 4.5 / Bromelain, ~30 GDU/L
0
20
40
60
80
100
0 10 20 30 40 50 60
Time, Minutes
%LC
Bromelain 30GDU-1 Bromelain 30GDU-2
Bromelain 30GDU_4-hour Bromelain 30GDU_7-hour
Solution Stability of Enzyme Media
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
38
• Enzyme activity will drop over time in solution
• From the observations of Bromelain and Papain media, it
suggests that the dissolution run should start within 4 hours
after the media is made. The media is no longer good after 7
hours.
• Pepsin and Pancreatin had not been tested for solution stability,
but the general rule from above may apply to them
Disintegration Evaluation:
Another Look from Different Hydrodynamics
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
39
• Bromelain @30 GDU/L
and Papain @525
KU/L have much
longer disintegration
time than Pepsin
• @6X works well (6
capsules in 1 beaker)
Disintegration of Cross-linked Capsules
(Individual Data)
0
5
10
15
20
25
30
W
ater
SG
F
SIF
Pepsin,1XPancreatin,1XBrom
elain,1X
Papain,1XBrom
elain,6X
Papain,6X
DisintegrationTime,Min.
0
2
4
6
8
10
12
14
16
18
20
W
ater
SG
F
SIF
Pepsin, 1X
Pancreatin, 1X
Brom
elain, 1X
Papain, 1X
Brom
elain, 6X
Papain, 6X
Disintegration of Cross-linked Capsules (Mean, N=6)
• Water can not open the X-linked
capsules within 15 minutes
• Pancreatin @1750 units/L is
weaker than SGF and Pepsin
(similar to dissolution results)
Summary: Recommended Levels of these four
Enzymes
Recommended
levels of
Enzymes:
•Pepsin: 750,000
Units/L (<711>),
i.e. 16,000,000
FCC units/L
•Pancreatin:
2000 Units/L
•Bromelain:
30 GDU/L
•Papain: 550,000
Units/L
(525,000 U/L may
be slightly too
weak and too
variable.)
40
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
Tier-2 Performance Comparison - All 4 Enzymes (N=12)
0
20
40
60
80
100
0 10 20 30 40 50 60
Time, Minutes
%LC
Pepsin/750000 U Pancreatin/2000 U
Bromelain/30 GDU Papain/550000 U
Normal Capsule (pH 6.8)
Tier-2 Performance Comparison - All 4 Enzymes (N=12)
0
20
40
60
80
100
0 10 20 30 40 50 60
Time, Minutes
%LC
Pepsin/750000 U Pancreatin/2000 U Bromelain/30 GDU Papain/525000 U
Summary and Next Step
• The gelatin dissolves faster in 0.1N HCl than pH 4.5 & pH 6.8
• SDS may interact with gelatin and show more variable results. The
impact is not significant for fast dissolving formulations
• Pepsin in 0.1N HCl is used as the reference, and identified the
appropriate levels for the other three enzymes
Next Steps:
• Verify these experiment results from other labs
• Verify working pH ranges for each enzymes
• Find the best way to express the enzyme activity, and be consistent
from various suppliers
41
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
• The design, study conduct, and financial support for the study
were provided by Abbvie. Abbvie participated in the
interpretation of data, review, and approval of the
presentation.
• Abbvie is the sole source of funding for the related studies in
this presentation. No other entity has provided any funding
for the related studies in this presentation.
Disclosures
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
42
Acknowledgement
• Dr. Jian-Hwa Han is employed at Abbvie. Dr. Han is the primary
investigator for this study.
• Mr. Daniel Bonilla is employed at Abbvie. Mr. Bonilla provided
technical assistance for this study.
• Ms. Susan George and Dr. Paul D. Curry, Jr. are employed at Abbvie
who have contributed for scientific discussions and reviewing the
presentation materials.
• Mr. Thomas Langdon of American Laboratories, Inc. provided all
four enzymes for this study, and the technical information about
these materials.
43
USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
Q&A
USP EP Meeting_2013 Final

More Related Content

What's hot

NOVEL IPQCL AND FPQC TEST FOR OPTHALMIC PREPARATION AS PER IP, BP A...
NOVEL IPQCL AND FPQC   TEST   FOR OPTHALMIC PREPARATION   AS   PER   IP, BP A...NOVEL IPQCL AND FPQC   TEST   FOR OPTHALMIC PREPARATION   AS   PER   IP, BP A...
NOVEL IPQCL AND FPQC TEST FOR OPTHALMIC PREPARATION AS PER IP, BP A...roshan telrandhe
 
Methyl parathion hydrolase
Methyl parathion hydrolaseMethyl parathion hydrolase
Methyl parathion hydrolaseanku00009
 
Dogan_East_Prague_June2011
Dogan_East_Prague_June2011Dogan_East_Prague_June2011
Dogan_East_Prague_June2011TacTac-RAS
 
Gilron_et_al-1999-Environmental_Toxicology_and_Chemistry
Gilron_et_al-1999-Environmental_Toxicology_and_ChemistryGilron_et_al-1999-Environmental_Toxicology_and_Chemistry
Gilron_et_al-1999-Environmental_Toxicology_and_ChemistryGuy Gilron
 
Determination of Insoluble Solids in Pretreated Biomass
Determination of Insoluble Solids in Pretreated BiomassDetermination of Insoluble Solids in Pretreated Biomass
Determination of Insoluble Solids in Pretreated BiomassBiorefineryEPC™
 

What's hot (7)

Flexible Automated Sample Prep Workflows
Flexible Automated Sample Prep WorkflowsFlexible Automated Sample Prep Workflows
Flexible Automated Sample Prep Workflows
 
NOVEL IPQCL AND FPQC TEST FOR OPTHALMIC PREPARATION AS PER IP, BP A...
NOVEL IPQCL AND FPQC   TEST   FOR OPTHALMIC PREPARATION   AS   PER   IP, BP A...NOVEL IPQCL AND FPQC   TEST   FOR OPTHALMIC PREPARATION   AS   PER   IP, BP A...
NOVEL IPQCL AND FPQC TEST FOR OPTHALMIC PREPARATION AS PER IP, BP A...
 
Methyl parathion hydrolase
Methyl parathion hydrolaseMethyl parathion hydrolase
Methyl parathion hydrolase
 
Dogan_East_Prague_June2011
Dogan_East_Prague_June2011Dogan_East_Prague_June2011
Dogan_East_Prague_June2011
 
Gilron_et_al-1999-Environmental_Toxicology_and_Chemistry
Gilron_et_al-1999-Environmental_Toxicology_and_ChemistryGilron_et_al-1999-Environmental_Toxicology_and_Chemistry
Gilron_et_al-1999-Environmental_Toxicology_and_Chemistry
 
Biolife
BiolifeBiolife
Biolife
 
Determination of Insoluble Solids in Pretreated Biomass
Determination of Insoluble Solids in Pretreated BiomassDetermination of Insoluble Solids in Pretreated Biomass
Determination of Insoluble Solids in Pretreated Biomass
 

Viewers also liked

Viewers also liked (20)

Network
NetworkNetwork
Network
 
Marketing ROI in the Era of Big Data
Marketing ROI in the Era of Big DataMarketing ROI in the Era of Big Data
Marketing ROI in the Era of Big Data
 
Vietnam.rb rom talk
Vietnam.rb rom talkVietnam.rb rom talk
Vietnam.rb rom talk
 
Toolkit for supporting social innovation with the ESIF
Toolkit for supporting social innovation with the ESIFToolkit for supporting social innovation with the ESIF
Toolkit for supporting social innovation with the ESIF
 
Pra latihan
Pra latihanPra latihan
Pra latihan
 
Latihan powerpoint
Latihan powerpointLatihan powerpoint
Latihan powerpoint
 
Pra latihan powerpoint
Pra latihan powerpointPra latihan powerpoint
Pra latihan powerpoint
 
Kisi kisi tik ukg 2015
Kisi kisi tik ukg 2015Kisi kisi tik ukg 2015
Kisi kisi tik ukg 2015
 
Shaping Sexuality - Robert Adolfsson - Design & sex
Shaping Sexuality - Robert Adolfsson - Design & sexShaping Sexuality - Robert Adolfsson - Design & sex
Shaping Sexuality - Robert Adolfsson - Design & sex
 
Written_CVB_SEOR_State
Written_CVB_SEOR_StateWritten_CVB_SEOR_State
Written_CVB_SEOR_State
 
Горнолыжная западная Европа
Горнолыжная западная ЕвропаГорнолыжная западная Европа
Горнолыжная западная Европа
 
Chris
ChrisChris
Chris
 
Shakespeare
ShakespeareShakespeare
Shakespeare
 
Presentation
PresentationPresentation
Presentation
 
Jacqueline rojas
Jacqueline rojasJacqueline rojas
Jacqueline rojas
 
Calendario de liga 2015 2016
Calendario de liga 2015 2016Calendario de liga 2015 2016
Calendario de liga 2015 2016
 
Cinematography research
Cinematography researchCinematography research
Cinematography research
 
The big picture
The big pictureThe big picture
The big picture
 
Mohammad Bahafzalla CV
Mohammad Bahafzalla CVMohammad Bahafzalla CV
Mohammad Bahafzalla CV
 
Strategic Process_ The Popcorn Factory_ Fixed basis Analysis presentation
Strategic Process_ The Popcorn Factory_ Fixed basis Analysis presentationStrategic Process_ The Popcorn Factory_ Fixed basis Analysis presentation
Strategic Process_ The Popcorn Factory_ Fixed basis Analysis presentation
 

Similar to USP EP Meeting_2013 Final

In Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage FromIn Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage FromSagar Savale
 
Dissolution procedure development and validation, USP 1092
Dissolution procedure development and validation, USP 1092Dissolution procedure development and validation, USP 1092
Dissolution procedure development and validation, USP 1092Md. Saddam Nawaz
 
Pradip digge
Pradip diggePradip digge
Pradip diggeswapy123
 
PattersonEWRI2014 (1)
PattersonEWRI2014 (1)PattersonEWRI2014 (1)
PattersonEWRI2014 (1)John Maziuk
 
AMV__Protocol-Gentamycin_Cream.doc
AMV__Protocol-Gentamycin_Cream.docAMV__Protocol-Gentamycin_Cream.doc
AMV__Protocol-Gentamycin_Cream.docvenkatesh naik
 
CHRONO THERAPEUTIC DRUG DELIVERY SYSTEM OF SALBUTAMOL SULPHATE FOR THE TREATM...
CHRONO THERAPEUTIC DRUG DELIVERY SYSTEM OF SALBUTAMOL SULPHATE FOR THE TREATM...CHRONO THERAPEUTIC DRUG DELIVERY SYSTEM OF SALBUTAMOL SULPHATE FOR THE TREATM...
CHRONO THERAPEUTIC DRUG DELIVERY SYSTEM OF SALBUTAMOL SULPHATE FOR THE TREATM...chalapathi inst. of pharmaceutical sciences
 
IPQC for tablets, capsules and ointments.pptx
IPQC for tablets, capsules and ointments.pptxIPQC for tablets, capsules and ointments.pptx
IPQC for tablets, capsules and ointments.pptxSureshPharamasivam
 
Formulation and Evaluation of immediate release tablet in treatment of overac...
Formulation and Evaluation of immediate release tablet in treatment of overac...Formulation and Evaluation of immediate release tablet in treatment of overac...
Formulation and Evaluation of immediate release tablet in treatment of overac...BhuminJain1
 
The world of proteases diversity and function-glitsoe amsterdam2014
The world of proteases diversity and function-glitsoe amsterdam2014The world of proteases diversity and function-glitsoe amsterdam2014
The world of proteases diversity and function-glitsoe amsterdam2014DSM Animal Nutrition & Health
 
Stability indicating rp hplc method development and validation for simultaneo...
Stability indicating rp hplc method development and validation for simultaneo...Stability indicating rp hplc method development and validation for simultaneo...
Stability indicating rp hplc method development and validation for simultaneo...Rajasekhar
 
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNETItem 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNETExternalEvents
 
Preparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteralPreparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteralsangram maskar
 
Overview of Summer Internship Projects
Overview of Summer Internship ProjectsOverview of Summer Internship Projects
Overview of Summer Internship ProjectsJami Turnquist
 
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Waters Corporation
 
So Many Solvents, So Little Time
So Many Solvents, So Little TimeSo Many Solvents, So Little Time
So Many Solvents, So Little TimeMilliporeSigma
 
Biopharmaceutics and Pharmacokinetics Practical Manual
Biopharmaceutics and Pharmacokinetics Practical ManualBiopharmaceutics and Pharmacokinetics Practical Manual
Biopharmaceutics and Pharmacokinetics Practical ManualReshma Fathima .K
 

Similar to USP EP Meeting_2013 Final (20)

In Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage FromIn Process Quality Control Tests (IPQC) for Solid Dosage From
In Process Quality Control Tests (IPQC) for Solid Dosage From
 
Dissolution procedure development and validation, USP 1092
Dissolution procedure development and validation, USP 1092Dissolution procedure development and validation, USP 1092
Dissolution procedure development and validation, USP 1092
 
Accurex Product Guide.pdf
Accurex Product Guide.pdfAccurex Product Guide.pdf
Accurex Product Guide.pdf
 
Pradip digge
Pradip diggePradip digge
Pradip digge
 
PattersonEWRI2014 (1)
PattersonEWRI2014 (1)PattersonEWRI2014 (1)
PattersonEWRI2014 (1)
 
AMV__Protocol-Gentamycin_Cream.doc
AMV__Protocol-Gentamycin_Cream.docAMV__Protocol-Gentamycin_Cream.doc
AMV__Protocol-Gentamycin_Cream.doc
 
CHRONO THERAPEUTIC DRUG DELIVERY SYSTEM OF SALBUTAMOL SULPHATE FOR THE TREATM...
CHRONO THERAPEUTIC DRUG DELIVERY SYSTEM OF SALBUTAMOL SULPHATE FOR THE TREATM...CHRONO THERAPEUTIC DRUG DELIVERY SYSTEM OF SALBUTAMOL SULPHATE FOR THE TREATM...
CHRONO THERAPEUTIC DRUG DELIVERY SYSTEM OF SALBUTAMOL SULPHATE FOR THE TREATM...
 
IPQC for tablets, capsules and ointments.pptx
IPQC for tablets, capsules and ointments.pptxIPQC for tablets, capsules and ointments.pptx
IPQC for tablets, capsules and ointments.pptx
 
Formulation and Evaluation of immediate release tablet in treatment of overac...
Formulation and Evaluation of immediate release tablet in treatment of overac...Formulation and Evaluation of immediate release tablet in treatment of overac...
Formulation and Evaluation of immediate release tablet in treatment of overac...
 
USP Disso_Bazil 2013_Spec v6
USP Disso_Bazil 2013_Spec v6USP Disso_Bazil 2013_Spec v6
USP Disso_Bazil 2013_Spec v6
 
The world of proteases diversity and function-glitsoe amsterdam2014
The world of proteases diversity and function-glitsoe amsterdam2014The world of proteases diversity and function-glitsoe amsterdam2014
The world of proteases diversity and function-glitsoe amsterdam2014
 
Stability indicating rp hplc method development and validation for simultaneo...
Stability indicating rp hplc method development and validation for simultaneo...Stability indicating rp hplc method development and validation for simultaneo...
Stability indicating rp hplc method development and validation for simultaneo...
 
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNETItem 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
Item 7 :Comparación de los *SOPs entre LATSOLAN y **SEALNET
 
Preparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteralPreparation of large volume and small volume parenteral
Preparation of large volume and small volume parenteral
 
Overview of Summer Internship Projects
Overview of Summer Internship ProjectsOverview of Summer Internship Projects
Overview of Summer Internship Projects
 
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
Comprehensive Investigation of the Utilization of SFC/ESI Positive Mode MS fo...
 
So Many Solvents, So Little Time
So Many Solvents, So Little TimeSo Many Solvents, So Little Time
So Many Solvents, So Little Time
 
Biopharmaceutics and Pharmacokinetics Practical Manual
Biopharmaceutics and Pharmacokinetics Practical ManualBiopharmaceutics and Pharmacokinetics Practical Manual
Biopharmaceutics and Pharmacokinetics Practical Manual
 
Dissolution
DissolutionDissolution
Dissolution
 
China PH SOP
China PH  SOPChina PH  SOP
China PH SOP
 

USP EP Meeting_2013 Final

  • 1. Jian-Hwa Han USP Expert Panel Meeting May 29-30, 2013 Using Enzymes for Dissolution - The Understandings from Gelatin to Enzymes SUB-TITLE, DATE
  • 2. • Dissolution Equipment and Apparatus • Gelatin Dissolution in Various Media • Reference Compound – Acetaminophen o Tablet vs. OE Capsule (Over-encapsulated Tablet sample) • Tier-2 Testing Performance Evaluation o Enzymes Information o Control of Experiments o Setting the Reference Point - <711> Pepsin o Equivalent Performance of other Enzymes o Reproducibility of Bromelain and Papain o Disintegration Evaluation • Summary & Next Step Presentation Outline USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 2
  • 3. Dissolution by FO-UV System USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 3 • System 1: Distek Opt-Diss FO-UV Dissolution System • System 2: Sotax with Rainbow FO-UV System • Advantage: Direct detection with details profiles (and w/o Sampling errors) • Apparatus 2 @ 50 rpm • Samples • Hard Gelatin Shell • Tylenol Tablet • OE Tylenol Sample • Cross-linked OE Tylenol Sample
  • 5. Gelatin Dissolution – Typical Media USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 5 • Data clearly show much faster dissolution rate in 0.1N HCl • The dissolution rates in pH 4.5, pH 6.8, and water are similar Dissolution of Hard Gelatin Shell - App 2 @ 50 rpm in Typical Dissolution Media 0.0 20.0 40.0 60.0 80.0 100.0 120.0 0.0 10.0 20.0 30.0 40.0 50.0 60.0 Time, Minutes %LC 0.1N HCl Acetate, pH 4.5 Phosphate, pH 6.8 Water
  • 6. Gelatin Dissolution – Surfactant Impact in Water USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 6 • Surfactants do slow down the dissolution of gelatin • The impact from POE and CTAB are not significant • SDS posts more impact, but it still within the variability Dissolution of Hard Gelatin Shell - App 2 @ 50 rpm Surfactant Impact in Water 0.0 20.0 40.0 60.0 80.0 100.0 120.0 0.0 10.0 20.0 30.0 40.0 50.0 60.0 Time, Minutes %LC Water 0.5% SDS in Water 0.5% POE in Water 0.2% CTAB in Water
  • 7. Gelatin Dissolution – Surfactant Impact in pH 6.8 Phosphate Media USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 7 • No significant impact observed in pH 6.8 Phosphate media with either SDS or POE10LE Dissolution of Hard Gelatin Shell - App 2 @ 50 rpm Surfactant Impact in pH 6.8 Phophaste Buffer 0.0 20.0 40.0 60.0 80.0 100.0 120.0 0.0 10.0 20.0 30.0 40.0 50.0 60.0 Time, Minutes %LC 0.5% SDS in pH 6.8 pH 6.8 Buffer 0.5% POE in pH 6.8
  • 8. Gelatin Dissolution – Surfactant Impact in 0.1N HCl Media USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 8 • No significant impact observed for POE in 0.1N HCl media • Significant impact observed for SDS in 0.1N HCl media!!! Dissolution of Hard Gelatin Shell - App 2 @ 50 rpm Surfactant Impact in 0.1N HCl 0.0 20.0 40.0 60.0 80.0 100.0 120.0 0.0 10.0 20.0 30.0 40.0 50.0 60.0 Time, Minutes %LC 0.5% SDS in HCl 0.1N HCl 0.5% POE in HCl
  • 9. Comparison of Gelatin Dissolution Time in Various Media USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 9 Note – In general, the capsule opens within 2 minutes in 0.1N HCl. Gelatin Dissolution Comparison 0 5 10 15 20 25 30 0.1 N HC l,900 m L 0.5% SDS/0.1N H C l 0.5% PO E/0.1N H Cl Phosphate,pH 6.8 0.5% SDS/pH 6.8 0.5% PO E/pH 6.8 W ater,900 m L 0.5% SDS/W ater 0.5% PO E/W ater 0.2% CTAB/W ater Time,Minutes >~25% Dissolved >~50% Dissolved
  • 10. Reference Drug Acetaminophen (Tylenol IR Tablet): Q: NLT 80% in 30 min.
  • 11. Reference Compound – Acetaminophen USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 11 • Tylenol 250 mg Tablet was used as the test drug • Size 0 HGC Used for the OE sample without filler
  • 12. Tablet vs. OE Capsule Dissolution – Typical Media USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 12 Gelatin Dissolution Research - Acetaminophen, 0.1N HCl 0 20 40 60 80 100 120 0 5 10 15 20 25 30 Time, Min. %LC HGC Shell Tylenol OE Capsule Tylenol Tablet Gelatin Dissolution Research - Acetaminophen, Water 0 20 40 60 80 100 120 0 5 10 15 20 25 30 Time, Min. %LC HGC Shell Tylenol OE Capsule Tylenol Tablet Gelatin Dissolution Research - Acetaminophen, pH 6.8 0 20 40 60 80 100 120 0 5 10 15 20 25 30 Time, Min. %LC HGC Shell Tylenol OE Capsule Tylenol Tablet Gelatin Dissolution Research - Acetaminophen, pH 4.5 0 20 40 60 80 100 120 0 5 10 15 20 25 30 Time, Min. %LC HGC Shell Tylenol OE Capsule Tylenol Tablet Full release (>85%) within 3 minutes from Tablet (for all conditions) Once capsule opens, the residual gelatin does not impact dissolution for this product. Full release (>85%) within 10 minutes from OE Capsule (for all conditions) 0.1N HCl pH 4.5 pH 6.8 Water
  • 13. Acetaminophen OE Capsule Dissolution – Surfactant Impact (in Water) USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 13 • Surfactant somewhat delays the drug release • SDS: high capsule-to- capsule variability • However, all conditions release >85% in 10 minutes Gelatin Dissolution Research - Acetaminophen OE Capsule, Surfactant Impact (in Water) 0 20 40 60 80 100 120 0 5 10 15 20 25 30 Time, Min. %LC Water Only 0.5% Tween-80 0.5% POE 0.5% CTAB 0.5% SDS
  • 14. Acetaminophen OE Capsule Dissolution – Surfactant Impact (in 0.1N HCl) USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 14 • Surfactants do NOT slow down the drug release in 0.1N HCL • CTAB and POE show slightly faster drug release rate (Very low gelatin dissolution rate in 0.5% SDS/HCl does not impact the drug release from OE Capsules – see slide #16) Gelatin Dissolution Research - Acetaminophen OE Capsule, Surfactant Impact (in 0.1N HCl) 0 20 40 60 80 100 120 0 5 10 15 20 25 30 Time, Min. %LC 0.1N HCl only 0.5% SDS 0.5% CTAB 0.5% POE Gelatin_SDS/HCl
  • 15. Acetaminophen OE Capsule Dissolution – Surfactant Impact (in pH 6.8 Phosphate) USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 15 • CTAB delays the capsule opening (> 5minutes) • SDS shows very high capsule-to- capsule variability, and did not release >85% at 10 minutes Gelatin Dissolution Research - Acetaminophen OE Capsule, Surfactant Impact (in pH 6.8 Phosphate) 0 20 40 60 80 100 120 0 5 10 15 20 25 30 Time, Min. %LC pH 6.8 Phosphate only 0.5% SDS 0.5% CTAB 0.5% POE
  • 16. Acetaminophen OE Capsule Dissolution – SDS (at 0.5%) Impact in Different Media USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 16 • More variable in water and pH 6.8 Phosphate • SDS/pH 6.8: did not release >85% at 10 minutes • However, all conditions can release >85% of drug in 15 minutes Gelatin Dissolution Research - Acetaminophen OE Capsule, SDS Impact in Various Media 0 20 40 60 80 100 120 0 5 10 15 20 25 30 Time, Min. %LC Water Only SDS in Water SDS in HCl SDS in pH 6.8
  • 17. Comparison of Acetaminophen Dissolution Time: Tablet vs. OE Capsule in Various Media USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 17 • The Tablet full releases the drug within 3 minutes (> 90% for all media tested) • The OE Capsule releases >85% drug within 10 minutes for all conditions tested Acetaminophen Dissolution Comparison - Tablet vs. OE Capsule (Tier-1) 0 1 2 3 4 5 6 7 8 9 10 0.1N H Cl, Tablet 0.1N H Cl, O E C apsule 0.5% SDS/0.1N H C l_C ap pH 4.5, Tablet pH 4.5, O E Capsule pH 6.8, Tablet pH 6.8, O E Capsule 0.5% CTAB/pH 6.8_C ap W ater, Tablet 0.5% Tween-80, Tablet W ater, O E C apsule 0.5% Tween-80, O E C ap 0.5% SDS, O E C apsule 0.5% PO E, O E C apsule 0.5% CTAB, O E C apsule Time,Minutes >=5% Release >=85% Released
  • 19. Enzymes Information (Currently in USP <711>) USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 19 Pepsin: • Manufacture: American Laboratories Inc. • Product: Pepsin, 1:10,000 Powder • Lot No: 00511010 • Pepsin Activity: 1:10,400 Pacreatin: • Manufacture: American Laboratories Inc. • Product: Pancreatin 8X USP Powder • Lot No: 52320708 • Activity: Protease: 8.1X USP (203 USP units/mg) Amylase: 10.2X USP (255 USP units/mg) Lipase: 33.7 USP Units/mg
  • 20. Enzymes Information (New) USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 20 Bromelain: • Manufacture: American Laboratories Inc. • Product: Bromelain 2400 GDU • Lot No: 55920701-A • Proteolytic Activity: 2,482 GDU/g Papain: • Manufacture: American Laboratories Inc. • Product: Papain Full Strength • Lot No: 70310665-B • Proteolytic Activity: 66,900 USP units/mg
  • 21. Control of Experiments USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 21 Need to get Reproducible results! (Consistency!) • Same Equipment and Apparatus • Same Analyst • Consistent Execution of Dissolution Runs • Direct Detection – Avoid sampling errors • Precise operation for generating cross-linked capsule samples: 2-hour Treatment with Formaldehyde
  • 22. <711> Tier-1 vs. Tier-2: Non-cross-linked Capsules USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 22 • No significant difference after 10 minutes Normal Capsule - 0.1N HCl 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC 0.1N HCl/Pepsin 0.1N HCl Normal Capsule - pH 6.8 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC pH 6.8 pH 6.8/Pancreatin Q: NLT 80% in 30 min.
  • 23. Tier-1, 0.1N HCl: Non-cross-linked Capsule vs. Cross-linked Capsule USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 23 • Fails Stage-3! • The ~same level of cross- linked capsule samples (i.e. 2- hour treated) were used for all Tier-2 experiments Tier-1, 0.1N HCl: Normal Capsule vs. X-linked Capsule 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC Normal_Tier-1_HCl Xlinked_Tier-1_HCl Q: NLT 80% in 30 min.
  • 24. Tier-1, pH 6.8: Non-cross-linked Capsule vs. Cross-linked Capsule USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 24 • Fails Stage-3!Tier-1, pH 6.8: Normal Capsule vs. X-linked Capsule 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC Normal_Tier-1_pH 6.8 Xlinked_Tier-1_pH 6.8 Q: NLT 80% in 30 min.
  • 25. <711> Pepsin, 750,000 Units/L USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 25 • Current <711> 750,000 units/L is equivalent to 16,000,000 FCC units/L • For X-linked capsule (2-hour treated with formaldehyde), Tier-2 result at 30 minutes is 92% (± 6.2%) May Pass S-1 of Tier-2 <711> Pepsin @ 750,000 Units/L 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC Normal_Tier-1_HCl Xlinked_Tier-2_HCl
  • 26. <711> Pancreatin, 1750 Units/L USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 26 • Current <711> 1750 units/L • For X-linked capsule (2-hour treated with formaldehyde), Tier-2 result at 30 minutes is 83% (± 10.6%) Will go to Stage-2 of Tier-2 <711> Pacreatin @ 1750 Units/L 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC Normal_Tier-1_pH 6.8 Xlinked_Tier-2_pH 6.8
  • 27. Finding Equivalent Pancreatin Level to Match Pepsin Performance USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 27 • Current <711> 1750 units/L (1X) • Levels tested: [Units/L] 1750 (1X), 2000, 2500, 3500 (2X), and 5250 (3X) • For 2000 Units/L, Tier-2 result at 30 minutes is 93% (± 4.0%)  May Pass S-1 of Tier-2 pH 6.8 / Pancreatin 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC Normal_Tier-2 Normal_Tier-1 Xlinked_Tier-1 Xlinked_Tier-2_3X Xlinked_Tier-2_2X Xlinked_Tier-2_1X Xlinked_Tier-2_2500U Xlinked_Tier-2_2000U 1750 Units/L 2000 Units/L 5250 Units/L (3X)
  • 28. pH 6.8 / Pancreatin 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC Normal_Tier-1 Xlinked_Tier-1 Xlinked_Tier-2_1X Xlinked_Tier-2_2000U Pepsin, <711> Pancreatin vs. Pepsin Performance USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 28 Pepsin, <711>
  • 29. Tier-1, pH 4.5: Non-cross-linked Capsule vs. Cross-linked Capsule USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 29 • Fails Stage-3! Tier-1, pH 4.5: Normal Capsule vs. X-linked Capsule 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC Normal_Tier-1_pH 4.5 Xlinked_Tier-1_pH 4.5 Q: NLT 80% in 30 min.
  • 30. Screening Bromelain at pH 4.5 to Match Pepsin Performance USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 30 • Starting point: 0.5 g/L (i.e. ~1250 GDU/L) • Levels tested: [GDU/L] 1250, 500, 100, 50, 40, 30, and 25 GDU/L • For 30 GDU/L, Tier-2 result at 30 minutes is 91% (± 7.0%)  Will Pass S-2 of Tier-2 pH 4.5 / Bromelain 0 20 40 60 80 100 0 10 20 30 40 50 60 Time, Minutes %LC Normal_Tier-1 X_Tier-1 X_Tier-2 (1250U) X_Tier-2 (500U) X_Tier-2 (100U) X_Tier-2 (50U) X_Tier-2 (40U) X-Tier-2 (30U) X-Tier-2 (25U) Very Effective! 25 GDU/L
  • 31. Bromelain vs. Pepsin Performance USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 31 pH 4.5 / Bromelain 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC Normal_Tier-1 Xlinked_Tier-1 Xlinked-Tier-2 (30U) Xlinked-Tier-2 (25U) Pepsin, <711> Pepsin, <711>
  • 32. Screening Papain at pH 4.5 to Match Pepsin Performance USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 32 • Starting point: 9 mg/L (i.e. ~600,000 U/L) • Levels tested: [KU/L] 600, 550, 525, and 500 KU/L • Very small amount of Papain Used: pH 4.5 / Papain 0 20 40 60 80 100 0 10 20 30 40 50 60 Time, Minutes %LC Normal_T1 X_T1 X_Tier-2 (600KU) X_Tier-2 (550KU-1) X_Tier-2 (550KU-2) X_Tier-2 (525KU-1) X_Tier-2 (525KU-2) X_Tier-2 (500KU) Units/L mg / 6L 600,000 53.8 550,000 49.3 525,000 47.1 500,000 44.9
  • 33. Screening Papain at pH 4.5 to Match Pepsin Performance (cont.) USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 33 • The results seem more variable than Bromelain • For 550 KU/L, Tier-2 result at 30 minutes is 95% (± 3.0%)  Too Good? • For 525 KU/L, Tier-2 result at 30 minutes is 85% (± 9.9%)  Will go to Stage-2 of Tier-2 pH 4.5 / Papain 0 20 40 60 80 100 0 10 20 30 40 50 60 Time, Minutes %LC Normal_T1 X_T1 X_Tier-2 (600KU) X_Tier-2 (550KU, N=12) X_Tier-2 (525KU, N=12) 525 KU/L
  • 34. Papain vs. Pepsin Performance USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 34 pH 4.5 / Papain 0 20 40 60 80 100 120 0 10 20 30 40 50 60 Time, Minutes %LC Normal_T1 Xlinked_T1 Xlinked_Tier-2 (550KU, N=12) Xlinked_Tier-2 (525KU, N=12) Pepsin, <711> Pepsin, <711>
  • 35. Stability of Papain Medium at 550,000 Units/L USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 35 • X-linked Capsule / Tier-2 Testing: Levels = 550 KU/L • After 7 hours, Tier-2 result at 30 minutes is 78% (± 15.3%)  May Fail the Tier-2 pH 4.5 / Papain, ~550 KU/L 0 20 40 60 80 100 0 10 20 30 40 50 60 Time, Minutes %LC Papain 550 kU-1 Papain 550 kU-2 Papain 550 kU_7 Hours
  • 36. Stability of Papain Medium at 525,000 Units/L USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 36 • X-linked Capsule / Tier-2 Testing: Levels = 525 KU/L • Up to 4 hours, the dissolution rate did not slow down • Overall, it shows high variability from run-to-run using Papain at 550 KU/L and 525 KU/L pH 4.5 / Papain, ~525 KU/L 0 20 40 60 80 100 0 10 20 30 40 50 60 Time, Minutes %LC Papain 525 kU-1 Papain 525 kU-2 Papain 525 kU_4 Hours
  • 37. Stability of Bromelain Medium at 30 GDU/L USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 37 • X-linked Capsule / Tier-2 Testing: Levels = 30 GDU/L • The dissolution rate are very consistent up to 4 hours • After 7 hours, Tier-2 result at 30 minutes is 70% (± 9.6%)  May Fail the Tier-2 pH 4.5 / Bromelain, ~30 GDU/L 0 20 40 60 80 100 0 10 20 30 40 50 60 Time, Minutes %LC Bromelain 30GDU-1 Bromelain 30GDU-2 Bromelain 30GDU_4-hour Bromelain 30GDU_7-hour
  • 38. Solution Stability of Enzyme Media USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 38 • Enzyme activity will drop over time in solution • From the observations of Bromelain and Papain media, it suggests that the dissolution run should start within 4 hours after the media is made. The media is no longer good after 7 hours. • Pepsin and Pancreatin had not been tested for solution stability, but the general rule from above may apply to them
  • 39. Disintegration Evaluation: Another Look from Different Hydrodynamics USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 39 • Bromelain @30 GDU/L and Papain @525 KU/L have much longer disintegration time than Pepsin • @6X works well (6 capsules in 1 beaker) Disintegration of Cross-linked Capsules (Individual Data) 0 5 10 15 20 25 30 W ater SG F SIF Pepsin,1XPancreatin,1XBrom elain,1X Papain,1XBrom elain,6X Papain,6X DisintegrationTime,Min. 0 2 4 6 8 10 12 14 16 18 20 W ater SG F SIF Pepsin, 1X Pancreatin, 1X Brom elain, 1X Papain, 1X Brom elain, 6X Papain, 6X Disintegration of Cross-linked Capsules (Mean, N=6) • Water can not open the X-linked capsules within 15 minutes • Pancreatin @1750 units/L is weaker than SGF and Pepsin (similar to dissolution results)
  • 40. Summary: Recommended Levels of these four Enzymes Recommended levels of Enzymes: •Pepsin: 750,000 Units/L (<711>), i.e. 16,000,000 FCC units/L •Pancreatin: 2000 Units/L •Bromelain: 30 GDU/L •Papain: 550,000 Units/L (525,000 U/L may be slightly too weak and too variable.) 40 USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 Tier-2 Performance Comparison - All 4 Enzymes (N=12) 0 20 40 60 80 100 0 10 20 30 40 50 60 Time, Minutes %LC Pepsin/750000 U Pancreatin/2000 U Bromelain/30 GDU Papain/550000 U Normal Capsule (pH 6.8) Tier-2 Performance Comparison - All 4 Enzymes (N=12) 0 20 40 60 80 100 0 10 20 30 40 50 60 Time, Minutes %LC Pepsin/750000 U Pancreatin/2000 U Bromelain/30 GDU Papain/525000 U
  • 41. Summary and Next Step • The gelatin dissolves faster in 0.1N HCl than pH 4.5 & pH 6.8 • SDS may interact with gelatin and show more variable results. The impact is not significant for fast dissolving formulations • Pepsin in 0.1N HCl is used as the reference, and identified the appropriate levels for the other three enzymes Next Steps: • Verify these experiment results from other labs • Verify working pH ranges for each enzymes • Find the best way to express the enzyme activity, and be consistent from various suppliers 41 USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
  • 42. • The design, study conduct, and financial support for the study were provided by Abbvie. Abbvie participated in the interpretation of data, review, and approval of the presentation. • Abbvie is the sole source of funding for the related studies in this presentation. No other entity has provided any funding for the related studies in this presentation. Disclosures USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013 42
  • 43. Acknowledgement • Dr. Jian-Hwa Han is employed at Abbvie. Dr. Han is the primary investigator for this study. • Mr. Daniel Bonilla is employed at Abbvie. Mr. Bonilla provided technical assistance for this study. • Ms. Susan George and Dr. Paul D. Curry, Jr. are employed at Abbvie who have contributed for scientific discussions and reviewing the presentation materials. • Mr. Thomas Langdon of American Laboratories, Inc. provided all four enzymes for this study, and the technical information about these materials. 43 USP Dissolution Workshop, Rio de Janeiro-Brazil, 2013
  • 44. Q&A

Editor's Notes

  1. 2
  2. 3
  3. 5
  4. 6
  5. 7
  6. 8
  7. 9
  8. 11
  9. 12
  10. 13
  11. 14
  12. 15
  13. 16
  14. 17
  15. 19
  16. 20
  17. 21
  18. 22
  19. 23
  20. 24
  21. 25
  22. 26
  23. 27
  24. 28
  25. 29
  26. 30
  27. 31
  28. 32
  29. 33
  30. 34
  31. 35
  32. 36
  33. 37
  34. 38
  35. 39
  36. 42